{
  "ptid_time": "021_S_5237_2019-07-30",
  "img_path": "/data/qiuhui/data/adni/images/021_S_5237/2019-07-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 45,528 mm³, 3.2% below the reference mean. With a Z-score of -0.09 (46.3th percentile), this represents normal volume ; whole brain volume measures 995,631 mm³, 3.3% below the reference mean. With a Z-score of -0.43 (33.5th percentile), this represents normal volume . ",
  "text_data": "Age is 86.3 years. Gender is Male. Education: 19 years. MMSE: 26.0. MoCA: 27.0. Logical Memory: 9.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.66 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The brain volumes (ventricular and whole brain) are within normal ranges, and cognitive scores (MMSE 26, MoCA 27) are above typical impairment thresholds. However, the presence of APOE4 and profoundly elevated AV45 (amyloid PET) suggests significant amyloid pathology, which is concerning for preclinical or early Alzheimer's changes despite preserved cognition.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (given amyloid burden but intact cognition, though close to normal)  \n**Confidence:** **Medium** (cognitive scores are strong, but amyloid burden is highly suggestive of early neurodegeneration)  \n\n*Alternative consideration:* **Cognitively Normal (CN) with high Alzheimer's risk**—if clinician judges no functional decline. Confidence would then be **Low** due to conflicting biomarkers.",
  "timestamp": "2025-07-26T01:56:32.184125"
}